Deanna M. Petersen, Chief Business Officer at AVROBIO joins Jason C. Foster on the new episode of Ori Spotlight. Having led mergers and acquisitions for some of the biggest names in biotech including Shire’s $4.2 billion acquisition of ViroPharma, Deanna is unquestionably a powerhouse leader in the space. Now, as the 4th employee at AVROBIO, she talks about how she built a pipeline of personalized gene therapies and some of the challenges she faced. The biggest? Chemistry, Manufacturing and Controls (CMC).
Learn more about Deanna M. Petersen | https://www.linkedin.com/in/dmpetersen/